vs
G III APPAREL GROUP LTD（GIII）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
G III APPAREL GROUP LTD的季度营收约是Royalty Pharma plc的1.6倍（$988.6M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 8.2%，领先26.3%），Royalty Pharma plc同比增速更快（4.8% vs -9.0%），过去两年G III APPAREL GROUP LTD的营收复合增速更高（13.7% vs 4.6%）
GIII服装集团是一家国际时尚企业，设计、生产及销售服装、鞋履、配饰等产品，拥有多个知名自有及授权品牌，覆盖休闲、运动、轻奢等多个品类，主要销往北美、欧洲等全球市场，合作客户包括百货商场、专业零售商及电商平台。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GIII vs RPRX — 直观对比
营收规模更大
GIII
是对方的1.6倍
$622.0M
营收增速更快
RPRX
高出13.8%
-9.0%
净利率更高
RPRX
高出26.3%
8.2%
两年增速更快
GIII
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $988.6M | $622.0M |
| 净利润 | $80.6M | $214.2M |
| 毛利率 | 38.6% | — |
| 营业利润率 | 11.4% | 62.4% |
| 净利率 | 8.2% | 34.4% |
| 营收同比 | -9.0% | 4.8% |
| 净利润同比 | -29.8% | 2.9% |
| 每股收益（稀释后） | $1.84 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GIIIRPRX
| Q4 25 | $988.6M | $622.0M | ||
| Q3 25 | $613.3M | $609.3M | ||
| Q2 25 | $583.6M | $578.7M | ||
| Q1 25 | $839.5M | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $644.8M | $564.7M | ||
| Q2 24 | $609.7M | $537.3M | ||
| Q1 24 | $764.8M | $568.0M |
净利润GIIIRPRX
| Q4 25 | $80.6M | $214.2M | ||
| Q3 25 | $10.9M | $288.2M | ||
| Q2 25 | $7.8M | $30.2M | ||
| Q1 25 | $48.8M | $238.3M | ||
| Q4 24 | $114.8M | $208.2M | ||
| Q3 24 | $24.2M | $544.0M | ||
| Q2 24 | $5.8M | $102.0M | ||
| Q1 24 | $28.9M | $4.8M |
毛利率GIIIRPRX
| Q4 25 | 38.6% | — | ||
| Q3 25 | 40.8% | — | ||
| Q2 25 | 42.2% | — | ||
| Q1 25 | 39.5% | — | ||
| Q4 24 | 39.8% | — | ||
| Q3 24 | 42.8% | — | ||
| Q2 24 | 42.5% | — | ||
| Q1 24 | 36.9% | — |
营业利润率GIIIRPRX
| Q4 25 | 11.4% | 62.4% | ||
| Q3 25 | 2.7% | 70.1% | ||
| Q2 25 | 1.5% | 36.3% | ||
| Q1 25 | 8.5% | 94.0% | ||
| Q4 24 | 15.3% | 60.9% | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 2.2% | 50.2% | ||
| Q1 24 | 6.1% | -13.0% |
净利率GIIIRPRX
| Q4 25 | 8.2% | 34.4% | ||
| Q3 25 | 1.8% | 47.3% | ||
| Q2 25 | 1.3% | 5.2% | ||
| Q1 25 | 5.8% | 41.9% | ||
| Q4 24 | 10.6% | 35.1% | ||
| Q3 24 | 3.8% | 96.3% | ||
| Q2 24 | 1.0% | 19.0% | ||
| Q1 24 | 3.8% | 0.8% |
每股收益（稀释后）GIIIRPRX
| Q4 25 | $1.84 | $0.49 | ||
| Q3 25 | $0.25 | $0.67 | ||
| Q2 25 | $0.17 | $0.07 | ||
| Q1 25 | $1.00 | $0.55 | ||
| Q4 24 | $2.55 | $0.46 | ||
| Q3 24 | $0.53 | $1.21 | ||
| Q2 24 | $0.12 | $0.23 | ||
| Q1 24 | $0.59 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.1M | $618.7M |
| 总债务越低越好 | $6.5M | $9.0B |
| 股东权益账面价值 | $1.8B | $9.7B |
| 总资产 | $2.8B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GIIIRPRX
| Q4 25 | $184.1M | $618.7M | ||
| Q3 25 | $301.8M | $938.9M | ||
| Q2 25 | $257.8M | $631.9M | ||
| Q1 25 | $181.4M | $1.1B | ||
| Q4 24 | $104.7M | $929.0M | ||
| Q3 24 | $414.8M | $950.1M | ||
| Q2 24 | $508.4M | $1.8B | ||
| Q1 24 | $507.8M | $843.0M |
总债务GIIIRPRX
| Q4 25 | $6.5M | $9.0B | ||
| Q3 25 | $6.9M | $8.9B | ||
| Q2 25 | $6.8M | $8.0B | ||
| Q1 25 | $3.0M | $7.6B | ||
| Q4 24 | $213.9M | $7.6B | ||
| Q3 24 | $402.5M | $7.6B | ||
| Q2 24 | $402.7M | $7.6B | ||
| Q1 24 | $402.8M | $6.1B |
股东权益GIIIRPRX
| Q4 25 | $1.8B | $9.7B | ||
| Q3 25 | $1.7B | $9.6B | ||
| Q2 25 | $1.7B | $9.5B | ||
| Q1 25 | $1.7B | $9.8B | ||
| Q4 24 | $1.6B | $10.3B | ||
| Q3 24 | $1.5B | $10.3B | ||
| Q2 24 | $1.5B | $9.8B | ||
| Q1 24 | $1.6B | $9.9B |
总资产GIIIRPRX
| Q4 25 | $2.8B | $19.6B | ||
| Q3 25 | $2.7B | $19.3B | ||
| Q2 25 | $2.4B | $18.3B | ||
| Q1 25 | $2.5B | $17.6B | ||
| Q4 24 | $2.8B | $18.2B | ||
| Q3 24 | $2.7B | $18.0B | ||
| Q2 24 | $2.6B | $17.7B | ||
| Q1 24 | $2.7B | $16.1B |
负债/权益比GIIIRPRX
| Q4 25 | 0.00× | 0.92× | ||
| Q3 25 | 0.00× | 0.93× | ||
| Q2 25 | 0.00× | 0.84× | ||
| Q1 25 | 0.00× | 0.78× | ||
| Q4 24 | 0.13× | 0.74× | ||
| Q3 24 | 0.27× | 0.74× | ||
| Q2 24 | 0.26× | 0.78× | ||
| Q1 24 | 0.26× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-97.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-106.4M | — |
| 自由现金流率自由现金流/营收 | -10.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | -1.21× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $367.7M | — |
8季度趋势，按日历期对齐
经营现金流GIIIRPRX
| Q4 25 | $-97.3M | $827.1M | ||
| Q3 25 | $75.1M | $702.6M | ||
| Q2 25 | $93.8M | $364.0M | ||
| Q1 25 | $333.4M | $596.1M | ||
| Q4 24 | $-111.8M | $742.5M | ||
| Q3 24 | $49.3M | $703.6M | ||
| Q2 24 | $45.5M | $658.2M | ||
| Q1 24 | $361.3M | $664.6M |
自由现金流GIIIRPRX
| Q4 25 | $-106.4M | — | ||
| Q3 25 | $64.7M | — | ||
| Q2 25 | $85.7M | — | ||
| Q1 25 | $323.7M | — | ||
| Q4 24 | $-120.3M | — | ||
| Q3 24 | $38.8M | — | ||
| Q2 24 | $32.8M | — | ||
| Q1 24 | $352.3M | — |
自由现金流率GIIIRPRX
| Q4 25 | -10.8% | — | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 14.7% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | -11.1% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 46.1% | — |
资本支出强度GIIIRPRX
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 1.2% | — |
现金转化率GIIIRPRX
| Q4 25 | -1.21× | 3.86× | ||
| Q3 25 | 6.86× | 2.44× | ||
| Q2 25 | 12.09× | 12.06× | ||
| Q1 25 | 6.83× | 2.50× | ||
| Q4 24 | -0.97× | 3.57× | ||
| Q3 24 | 2.04× | 1.29× | ||
| Q2 24 | 7.84× | 6.45× | ||
| Q1 24 | 12.52× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GIII
| Proprietary Brands | $498.1M | 50% |
| Licensed Brands | $479.2M | 48% |
| Retail Segment | $45.7M | 5% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
